Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001829126-24-005657
Filing Date
2024-08-19
Accepted
2024-08-19 16:23:26
Documents
4

Document Format Files

Seq Description Document Type Size
1 425 titanpharma_425.htm 425 73281
2 EXHIBIT 2.1 titanpharma_ex2-1.htm EX-2.1 802525
3 EXHIBIT 99.1 titanpharma_ex99-1.htm EX-99.1 21279
4 GRAPHIC ex99-1_001.jpg GRAPHIC 11053
  Complete submission text file 0001829126-24-005657.txt   914182
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Filed by) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Subject) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-13341 | Film No.: 241220867
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)